There are no controlled human trials establishing that KPV treats or prevents any inflammatory condition in people, and certainly none testing KPV as part of a four-peptide blend
Boada M, Lpez OL, Olazarn J, et al
A 2021 review of trials in older adults found magnesium shortened sleep-onset time in pooled results
Together this phenomenon is collectively referred to as the gray market. This gray market is not subject to the quality control regulations that govern the pharmaceutical industry, and testing conducted on a range of peptides including MOTS-c, BPC-157, TB-500, and CJC-1295 by The New Yorker in April showed that many were impure or contained less than the advertised dose
A realistic timeline for topical approaches generally looks like this: the first 4-8 weeks typically show no visible change, and some people experience a temporary increase in shedding as follicles synchronize
Moving from 0.5% to 1%, or from 1% to 2%, represents appropriate steps